These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 11861412)

  • 1. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
    Galis ZS; Khatri JJ
    Circ Res; 2002 Feb; 90(3):251-62. PubMed ID: 11861412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
    Newby AC
    Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular remodeling and protease inhibition--bench to bedside.
    Sluijter JP; de Kleijn DP; Pasterkamp G
    Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin and matrix metalloproteinases in vascular remodeling.
    Lijnen HR
    Thromb Haemost; 2001 Jul; 86(1):324-33. PubMed ID: 11487021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation.
    Okamoto T; Akuta T; Tamura F; van Der Vliet A; Akaike T
    Biol Chem; 2004 Nov; 385(11):997-1006. PubMed ID: 15576319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases.
    Lagente V; Boichot E
    J Mol Cell Cardiol; 2010 Mar; 48(3):440-4. PubMed ID: 19818795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
    Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
    Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
    J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification.
    Bailey M; Pillarisetti S; Jones P; Xiao H; Simionescu D; Vyavahare N
    Cardiovasc Pathol; 2004; 13(3):146-55. PubMed ID: 15081471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
    Cleutjens JP; Creemers EE
    J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.